Boehnlein Glenn S
- SEC CIK
- 0001670936
No open-market purchases or sales filed in the past year.
Current role at each company
- DXCM Dexcom IncDirectoras of Sep 10, 2026
- A Agilent Technologies, Inc.Directoras of Sep 10, 2026
- INGN Inogen IncDirectoras of Jun 9, 2026
- SYK Stryker CorpVP, Chief Financial Officeras of Mar 25, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Boehnlein Glenn S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SYK Stryker Corp
VP, Chief Financial Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2024 (view filing) | Aug 2 | Same day | Boehnlein Glenn SVP, Chief Financial Officer | SSale | −20.0K | $333.00 | −$6.66M | −87.5%2.85K after | |
| May 16, 2024 (view filing) | May 15 | 1 day | Boehnlein Glenn SVP, Chief Financial Officer | SSale | −10.0K | $327.65 | −$3.28M | −40.0%15.0K after | |
| Feb 12, 2024 (view filing) | Feb 9 | 3 days | Boehnlein Glenn SVP, Chief Financial Officer | SSale | −9.60K | $342.81 | −$3.29M | −32.2%20.2K after | |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Boehnlein Glenn SVP, Chief Financial Officer | SSale | −24.4K | $278.54 | −$6.80M | −91.0%2.43K after | 4 lots |
| Dec 14, 2021 (view filing) | Dec 10 | 4 days | Boehnlein Glenn SVP, Chief Financial Officer | SSale | −2.78K | $259.79 | −$721.7K | −17.5%13.1K after | 3 lots |